![Matthew Lang](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Matthew Lang
Geschäftsführer bei
STRUCTURE THERAPEUTICS INC.
Vermögen: 3 Mio $ am 30.06.2026
Profil
Mr. Matthew Lang is a Chief Operating Officer & General Counsel at Structure Therapeutics, Inc. Mr. Lang was previously employed as a Chief Legal Officer & Secretary by Metsera, Inc., a Secretary, Chief Legal & Business Officer by Lyell Immunopharma, Inc., a Secretary, Chief Administrative & Legal Officer by Myovant Sciences Ltd., a Secretary, Chief Administrative & Legal Officer by Myovant Sciences, Inc., a VP & Head- Global Litigation & Investigations by Gilead Sciences, Inc., an Attorney by Dechert LLP, and a Chairman-Management Board by Sumitomo Pharma Switzerland GmbH.
He also served on the board at United Way of the Bay Area.
He received his undergraduate degree from Queen's University and a graduate degree from The University of Pennsylvania Law School.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 15.04.2026 | 184.614 ( 0,13 % ) | 3 Mio $ | 30.06.2026 |
Aktive Positionen von Matthew Lang
| Unternehmen | Position | Beginn |
|---|---|---|
| STRUCTURE THERAPEUTICS INC. | Geschäftsführer | 15.04.2026 |
Ehemalige bekannte Positionen von Matthew Lang
| Unternehmen | Position | Ende |
|---|---|---|
| LYELL IMMUNOPHARMA, INC. | General Counsel | 13.04.2025 |
Myovant Sciences, Inc.
 Myovant Sciences, Inc. Medical SpecialtiesHealth Technology Develops therapeutics for women''s health and prostate cancer | Verwaltungsdirektor | 01.01.2023 |
United Way of the Bay Area
 United Way of the Bay Area Miscellaneous Commercial ServicesCommercial Services Owns and operates charities | Direktor/Vorstandsmitglied | 01.01.2018 |
| GILEAD SCIENCES, INC. | Corporate Officer/Principal | 01.07.2017 |
Ausbildung von Matthew Lang
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
91
Beziehungen ersten Grades
10
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 10 |
|---|---|
Gilead Sciences, Inc.
 Gilead Sciences, Inc. BiotechnologyHealth Technology Discovers, develops and commercializes therapeutic products and treatments for life threatening diseases | Health Technology |
Queen's University
 Queen's University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Dechert LLP
 Dechert LLP Miscellaneous Commercial ServicesCommercial Services Operates as a law firm | Commercial Services |
United Way of the Bay Area
United Way of the Bay Area Miscellaneous Commercial ServicesCommercial Services Owns and operates charities | Commercial Services |
The University of Pennsylvania Law School
 The University of Pennsylvania Law School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Myovant Sciences, Inc.
Myovant Sciences, Inc. Medical SpecialtiesHealth Technology Develops therapeutics for women''s health and prostate cancer | Health Technology |
Myovant Sciences Ltd.
 Myovant Sciences Ltd. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company which provides women's health and prostate cancer solutions | Health Technology |
Myovant Sciences GmbH
 Myovant Sciences GmbH BiotechnologyHealth Technology Engages in development and marketing of biopharmaceutical products | Health Technology |
Lyell Immunopharma, Inc.
 Lyell Immunopharma, Inc. BiotechnologyHealth Technology Develops cell-based immunotherapies for human diseases | Health Technology |
Structure Therapeutics, Inc.
 Structure Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company which develops molecule therapeutics to treat chronic diseases | Health Technology |
